Re-purposed drive-through vaccination set-up for Mpox, New York Metropolitan Area

Re-purposed drive-through vaccination set-up for Mpox, New York Metropolitan Area

Summary: Background: This report details how one large medical center in the Metropolitan New York area re-purposed a drive-through COVID-19 vaccination structure to handle a surge in Mpox cases in July 2022.Methods/Results: Simultaneous to on-going COVID -19 vaccination and testing, Mpox vaccinati...

Olles dieđut

Bibliográfalaš dieđut
Váldodahkkit: Marina Keller, Vishnu Chaturvedi, Rebecca Glassman, Donald S. Chen, Marc El-Khoury, Mary Dundas, Nicholas Feola, Varghese Thankachen, Marie Yezzo, Keri Tone, Justin Williams, Renee Garrick
Materiálatiipa: Artihkal
Giella:English
Almmustuhtton: Elsevier 2023-12-01
Ráidu:Infection Prevention in Practice
Fáttát:
Monkeypox
Mpox
Vaccine drive-through
Epidemic surge
Jynneos
Intradermal
Liŋkkat:http://www.sciencedirect.com/science/article/pii/S2590088923000495
Govvádus
Čoahkkáigeassu:Summary: Background: This report details how one large medical center in the Metropolitan New York area re-purposed a drive-through COVID-19 vaccination structure to handle a surge in Mpox cases in July 2022.Methods/Results: Simultaneous to on-going COVID -19 vaccination and testing, Mpox vaccination was rolled out in the same drive through structure. More than 1,820 Jynneos (Smallpox and Monkeypox Vaccine, Live, Non-replicating) vaccine dosages were delivered subcutaneously and then intradermally to 1,123 individuals through the open window of their vehicles, averaging 8–10 patients an hour. Five vaccine recipients suffered Mpox rash; there was no exposure among healthcare providers. Conclusion: Drive-through vaccination is an efficient model to be redeployed for future unexpected vaccine initiatives.
ISSN:2590-0889

Geahča maid